Financial Summary (All financials)
| In millions, except per share items | Dec-31-03 | Dec-31-02 | Dec-31-01 | Dec-31-00 | Dec-31-99 |
| Revenues | 310.6 | 267.1 | 225.0 | 156.6 | 176.7 |
| Revenue growth | 16.3% | 18.7% | 43.7% | -11.4% | |
| Cost of goods sold | 143.4 | 120.3 | 97.8 | 72.9 | 63.4 |
| Gross profit | 167.2 | 146.8 | 127.2 | 83.6 | 113.3 |
| Gross margin | 53.8% | 55.0% | 56.5% | 53.4% | 64.1% |
| Sales and marketing | 86.0 | 72.9 | 53.8 | 25.7 | 44.9 |
| Research and development | 6.1 | 4.9 | 7.1 | 4.1 | 2.9 |
| General and administrative | 29.6 | 24.7 | 24.9 | 21.0 | 19.7 |
| EBIT | 45.4 | 44.2 | 15.8 | 32.8 | 45.7 |
| EBIT margin | 14.6% | 16.6% | 7.0% | 21.0% | 25.9% |
| Pre-tax income | 36.4 | 12.9 | 11.8 | 56.1 | 47.8 |
| Income taxes | 9.8 | 5.7 | 5.2 | 17.2 | 11.3 |
| Tax rate | 27.0% | 44.1% | 44.5% | 30.6% | 23.8% |
| Net income | 26.6 | 7.2 | 6.5 | 38.9 | 36.4 |
| Net margin | 8.6% | 2.7% | 2.9% | 24.9% | 20.6% |
| |
| Diluted EPS | $1.11 | $0.31 | $0.28 | $1.68 | $1.60 |
| Shares outstanding (diluted) | 23.9 | 23.6 | 23.4 | 23.2 | 22.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|